Extended follow up of the TARGIT-A trial

Not Applicable

• Conditions: Breast cancer; Cancer; Malignant neoplasm of breast

• Registration Number: ISRCTN86287193
• Lead Sponsor: niversity College London

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-04-25
• Last Update Posted: 4 October 2021
• Study Completion: 2023-01-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: Female
• Target Recruitment: 3451

Inclusion Criteria

1. All patients who participated in the TARGIT-A trial
2. Female
3. 45 years and older

Exclusion Criteria

1. Any patient who has withdrawn consent for further follow-up, or died
2. Any patient who is unable to give formal written consent

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Self-reported health status through direct patient contact [Time Frame: 60 months]

Secondary Outcome Measures

Name	Time	Method
Death and new primary cancer data from UK patients, collected through the Office for National Statistics [Time Frame: Up to 20 years]